142 related articles for article (PubMed ID: 15507874)
21. Novel transglutaminase inhibitors reverse the inflammation of allergic conjunctivitis.
Sohn J; Kim TI; Yoon YH; Kim JY; Kim SY
J Clin Invest; 2003 Jan; 111(1):121-8. PubMed ID: 12511595
[TBL] [Abstract][Full Text] [Related]
22. Targeted delivery of a novel group of site-directed transglutaminase inhibitors to the liver using liposomes: a new approach for the potential treatment of liver fibrosis.
Daneshpour N; Griffin M; Collighan R; Perrie Y
J Drug Target; 2011 Sep; 19(8):624-31. PubMed ID: 21067461
[TBL] [Abstract][Full Text] [Related]
23. The mechanism of transglutaminase 2 inhibition with glucosamine: implications of a possible anti-inflammatory effect through transglutaminase inhibition.
Jeong KC; Ahn KO; Lee BI; Lee CH; Kim SY
J Cancer Res Clin Oncol; 2010 Jan; 136(1):143-50. PubMed ID: 19655169
[TBL] [Abstract][Full Text] [Related]
24. Transglutaminases as targets for pharmacological inhibition.
Wodzinska JM
Mini Rev Med Chem; 2005 Mar; 5(3):279-92. PubMed ID: 15777262
[TBL] [Abstract][Full Text] [Related]
25. Autoantibodies in celiac disease.
Alaedini A; Green PH
Autoimmunity; 2008 Feb; 41(1):19-26. PubMed ID: 18176861
[TBL] [Abstract][Full Text] [Related]
26. A fluorescence anisotropy-based assay for determining the activity of tissue transglutaminase.
Hauser C; Wodtke R; Löser R; Pietsch M
Amino Acids; 2017 Mar; 49(3):567-583. PubMed ID: 26886924
[TBL] [Abstract][Full Text] [Related]
27. Transglutaminases in disease.
Kim SY; Jeitner TM; Steinert PM
Neurochem Int; 2002 Jan; 40(1):85-103. PubMed ID: 11738475
[TBL] [Abstract][Full Text] [Related]
28. A role for anti-transglutaminase 2 autoantibodies in the pathogenesis of coeliac disease?
Lindfors K; Kaukinen K; Mäki M
Amino Acids; 2009 Apr; 36(4):685-91. PubMed ID: 18594945
[TBL] [Abstract][Full Text] [Related]
29. Novel transglutaminase inhibitors reduce the cornified cell envelope formation.
Kim SY; Park WM; Jung SW; Lee J
Biochem Biophys Res Commun; 1997 Apr; 233(1):39-44. PubMed ID: 9144392
[TBL] [Abstract][Full Text] [Related]
30. Novel 3-arylethynyl-substituted thieno[3,4-b]pyrazine derivatives as human transglutaminase 2 inhibitors.
Kim N; Kwak SH; Lee SH; Juvekar V; Lee BI; Ahn HC; Kim SY; Gong YD
Org Biomol Chem; 2014 Jul; 12(27):4932-40. PubMed ID: 24879506
[TBL] [Abstract][Full Text] [Related]
31. Surfactant protein of the Streptomyces subtilisin inhibitor family inhibits transglutaminase activation in Streptomyces hygroscopicus.
Zhang D; Wang M; Du G; Zhao Q; Wu J; Chen J
J Agric Food Chem; 2008 May; 56(9):3403-8. PubMed ID: 18380462
[TBL] [Abstract][Full Text] [Related]
32. Anti-cancer effect of a quinoxaline derivative GK13 as a transglutaminase 2 inhibitor.
Lee SH; Kim N; Kim SJ; Song J; Gong YD; Kim SY
J Cancer Res Clin Oncol; 2013 Aug; 139(8):1279-94. PubMed ID: 23604466
[TBL] [Abstract][Full Text] [Related]
33. Tissue transglutaminase-induced down-regulation of matrix metalloproteinase-9.
Ahn JS; Kim MK; Hahn JH; Park JH; Park KH; Cho BR; Park SB; Kim DJ
Biochem Biophys Res Commun; 2008 Nov; 376(4):743-7. PubMed ID: 18809380
[TBL] [Abstract][Full Text] [Related]
34. Allosteric inhibition site of transglutaminase 2 is unveiled in the N terminus.
Kim N; Kang JH; Lee WK; Kim SG; Lee JS; Lee SH; Park JB; Kim KH; Gong YD; Hwang KY; Kim SY
Amino Acids; 2018 Nov; 50(11):1583-1594. PubMed ID: 30105541
[TBL] [Abstract][Full Text] [Related]
35. A new regulatory mechanism of NF-kappaB activation by I-kappaBbeta in cancer cells.
Kim JM; Voll RE; Ko C; Kim DS; Park KS; Kim SY
J Mol Biol; 2008 Dec; 384(4):756-65. PubMed ID: 18950638
[TBL] [Abstract][Full Text] [Related]
36. Transglutaminases - possible drug targets in human diseases.
Gentile V; Cooper AJ
Curr Drug Targets CNS Neurol Disord; 2004 Apr; 3(2):99-104. PubMed ID: 15078184
[TBL] [Abstract][Full Text] [Related]
37. Tissue transglutaminase in celiac disease: role of autoantibodies.
Caputo I; Barone MV; Martucciello S; Lepretti M; Esposito C
Amino Acids; 2009 Apr; 36(4):693-9. PubMed ID: 18600381
[TBL] [Abstract][Full Text] [Related]
38. Characterization of purified rat testicular transglutaminase and age-dependent changes of the enzyme activities.
Wu YW; Lai WF; Tsai YH
Int J Biochem Cell Biol; 2005 Feb; 37(2):386-96. PubMed ID: 15474983
[TBL] [Abstract][Full Text] [Related]
39. A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease.
Dørum S; Qiao SW; Sollid LM; Fleckenstein B
J Proteome Res; 2009 Apr; 8(4):1748-55. PubMed ID: 19239248
[TBL] [Abstract][Full Text] [Related]
40. The prostate transglutaminase (TGase-4, TGaseP) regulates the interaction of prostate cancer and vascular endothelial cells, a potential role for the ROCK pathway.
Jiang WG; Ablin RJ; Kynaston HG; Mason MD
Microvasc Res; 2009 Mar; 77(2):150-7. PubMed ID: 18983858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
